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A bstract Nephrogenic diabetes insipidus (NDI) usually 
shows an X-linked recessive mode of inheritance caused 
by mutations in the vasopressin type 2 receptor gene 
(AVPR2). In the present study, three NDI families are de­
scribed in which females show clinical features resembling 
the phenotype in males. Maximal urine osmolality in three 
female patients did not exceed 200 mosmol/kg and the ab­
sence of extra-renal responses to l-desamino-8-D-arginine 
vasopressin was demonstrated in two of them. All affected 
females and two asymptomatic female family members 
were shown to be heterozygous for an AVPR2 mutation. 
Skewed X-inactivation is the most likely explanation for 
the clinical manifestation of NDI in female carriers of an 
AVPR2 mutation. It is concluded that, in female NDI pa­
tients, the possibility of heterozygosity for an AVPR2 gene 
mutation has to be considered in addition to homozygosity 
for mutations in the aquaporin 2 gene.
Introduction
Congenital nephrogenic diabetes insipidus (NDI) is a 
hereditary renal disorder occurring predominantly in 
males. The disease is characterized by failure of the kid­
ney to concentrate urine in response to the neurohypophy­
seal hormone arginine vasopressin. As a consequence, 
large volumes of urine are produced (polyuria), resulting 
in a water loss that has to be compensated by ingestion of 
a similar quantity of fluid (polydipsia). Most patients pre­
sent in their first year of life with aspecific symptoms, 
such as vomiting, anorexia, growth retardation and fever.
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After infanthood, the clinical picture is dominated by the 
less alarming symptoms of polyuria and polydipsia*
In most families, NDI shows an X-linked recessive 
mode of inheritance; female carriers have no or only mild 
symptoms of the disease. In 1992, this form of NDI was 
found to be caused by mutations in the vasopressin type 2 
receptor gene (AVPR2) (van den Ouwelaiul et al. 1992; Pan 
et al. 1992; Rosenthal et al. 1992). Several families have 
been reported, however, in which females are affected by 
the disease from childhood (Table I h One explanation lor 
the complete manifestation of the disease in females was 
recently found when mutations in ihe aquaporin 2 {AQP2) 
water channel gene were shown to cause autosomal reces­
sive NDI (Deen et a l  1994; van Lieburg et aL 1994), Fur­
thermore, affected females have been described in fami­
lies in which inheritance of NDI seemed dominant (Can­
non 1955; Robinson and Kaplan I960; Oh/eki et al. 1984; 
Matsumoto et al. 1988; Niaudet et al. 1985). This heredity
♦
pattern could, theoretically, reflect the presence of another 
defect that interferes with signal transduction somewhere 
between the receptor and water channel. Finally, it has 
been suggested that the expression of X-linked NDI can 
be nearly complete in female carriers but, to our knowl­
edge, this hypothesis has never been substantiated by 
DNA analysis (Wiggelinkhuizen et al. 1 ^73; Culpepper el 
al. 19X3; Braden et al. 1985; McKusick 1986; Aggnrwal 
et al. 1986; Moses et al, 1988). Here, we report three NI)l 
families in which female carriers of an AVPR2 mutation 
show a clinical phenotype similar to male NDI patients.
Patients, materials and methods
The human studies performed by ihe NDI research group have 
been reviewed by the Ethics Committee of the University of Nil- 
megen.
Patients 
Family I
The iemale patient (IV.I) in this Austrian family (big, I A) was bum 
at term after an uncomplicated pregnancy. Family Iiimoiy was neg»
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T able  1 Female N Di-patients" 
reported in literature (/// months, 
V years, D H T  dehydration test, 
AVP  after A VP; DDAVP  after 
DDAVP, ONFD  overnight 
fluid deprivation)
Only patients reported to be 
affected from childhood are 
mentioned
Specific gravity
Author Age at 
presentation
M axim al urine 
osmolalaty o r  s .g .b
Affected family members
Dancis et al. (1948) 6.5 m 1016b (DHT) 
1006b (AVP)
No
Carter and Simpkiss (1956) In childhood 1018b (ON FD) Son
In childhood 101 lb (ONFD) Son o f  sister
Brodehl and Braun (1964) 2 m 80 (during dehydration) Father (mildly affected)
Feigin et al. (1970) 3 y 82 (DHT) 2  brothers, I half-brother
Wiggelinkhuizen et al. (1973) 3 m 80 (AVP) Brother
Zimmermann and Green (1975) 2.8 y 55 (AVP) N o
Schreiner et al. (1978) 1.3 y 75 (AVP) No
Niaudet et al. (1985) ?* Completely  unres­
ponsive (D D A V P )
Several females
Aggarwal et al. (1986) 3 m 148 (AVP) No
Brenner el al. (1988) 7-11 y 82 (AVP) 2  brothers
3 m 70 (AVP) 1 brothers
Moses et al, (1988) In childhood 101 (DDAVP) No
Schofer et al. (1990) 6 m 160 (AVP) No
Langley et al. (1991) 1 m 1000b (AVP) Sister
2 m 1000h (AVP) Sister
Pal lacks et al. (1991) 3 m *7 Father
ative for ND1 and her parents were not known to be consan­
guineous, On the seventh day of life, the girl was hospitalized be­
cause of diarrhoea with hypertonic dehydration. At admission» 
serum sodium was 156 mmol/I; urine osmolality was not mea­
sured. Escherichia colt was isolated from her blood, She was 
treated successfully with intravenous fluid and antibiotics and dis­
charged two weeks after admission.
The following year her brother (IV.2) was born. He was admit­
ted on the tenth day of life in a dehydrated condition (serum 
sodium 166 mmol/1, serum osmolality 357 mosmol/kg). Diarrhoea 
anil fever had been present for one week. Despite dehydration, 
urine osmolality was low (118 mosmol/kg). After intravenous 
fluid therapy, the child was noticed to be excessively thirsty and 
polyuric (intake 360 ml/kg per day). A dehydration test with sub­
sequent administration of 1-desamino-B-o-arginine vasopressin 
(DDAVP) was performed, resulting in a maximum urine osmolal­
ity of 152 mosmol/kg with a concurrent serum osmolality of 313 
mosmol/l (Table 2). lie was treated with hydrochlorothiazide and 
an ample supply of fluid, a regimen on which daily urine produc­
tion amounted to 250 ml/kg and serum osmolality remained in 
the normal range. Now, at the age o f  19 months, his fluid intake 
is 2 5 0 -2 9 0  ml/kg per day (medication hydrochlorothiazide and 
amiloride). Growth and mental development are normal.
Because of the diagnosis of NDI in this boy, attention was 
again focussed on his sister, A renewed medical history revealed 
that she had been excessively thirsty and polyuric since birth. At 
the age of two years, the girl was hospitalized for further evaluation. 
She was in good general condition (weight and stature P25). Serum 
osmolality, sodium and potassium were normal; random urine os­
molality was low (82 mosmol/kg). Oral fluid intake ranged from 
260 to 350 ml/kg/day. A dehydration test did not result in a normal 
increase of urine osmolality, neither did intravenous administra­
tion of DDAVP (Table 2). Now, at the age o f  3 years, she has a 
fluid intake of 300 ml/kg per day (medication hydrochlorothiazide 
and amiloride), Growth and mental development are normal. The 
mother of these children has no symptoms of  NDI (daily urine pro­
duction 1 1).
Fam ily  2
The female proband (IV,15) in this Dutch family (F ig .IB ) was 
born at term, The pregnancy was complicated by fluxus and hy- 
peremesis after 3 months, m ild  hypertension and maternal varico- 
sis for which aspirin was used. T he  girl had feeding problems from 
birth; she vomited frequently and show ed aversion to solid foods. 
Growth retardation became m anifest  at the age o f  14 weeks. W hen 
she was 8 months old, she was referred to a  pediatrician because of 
persistent feeding problems and growth retardation (length P m, 
weight < P3). At laboratory exam ination , a high serum sodium 
concentration (157 mmol/1) and serum osmolality (319 m osm ol/ 
kg) were found. A D D A V P  test showed a minimal increase of 
urine specific gravity (Table 2). A n  intravenous pyelogram (IVP) 
revealed no abnormalities. Fluid intake ad libitum and administra­
tion o f  hydrochlorothiazide in com bination  with a salt-restricted 
diet resulted in normalization o f  serum sodium and osmolality and 
she was discharged 9 weeks after admission. At present (age 13), 
daily urine production am ounts  to 150 ml/kg (medication hy­
drochlorothiazide), She show s normal mental development but is 
small for her age (< P |{>).
Family history revealed that the m other  (111.7) had a large fluid 
intake since childhood. W hen  she was in primary school, she was 
hospitalized because o f  severe vomiting. In the same period, dia­
betes mellitus was excluded as a  possible cause o f  her polydipsia. 
At the age of 33, as a consequence  o f  the diagnosis made in her 
daughter, a DDAVP test was performed, which showed impairment 
of her anti-diuretic response (Table 2). An I VP showed slight dila­
tion of  the right pyelum and ureter. T rea tm ent with chlorthalidon 
and a salt-restricted diet resulted in a decrease o f  polydipsia and 
polyuria. Except for bile stones, for  which cholecystectomy was 
performed, she has had no m ajor medical problems. Sym ptom s of 
NDI were absent from the other family m em bers. Urine osmolality 
after overnight fluid deprivation o f  the fa ther of patient IV. 15 was 
normal (905 mosmol/kg). H er sister show ed a borderline value 
(735 mosmol/kg).
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Fig. 1A -C  Pedigrees of the 
NDI families. Black sym bols  
denote affected individuals; 
hatched symbols  indicate that 
NDI is suspected; symbols with 
¿Hag on a I slashes  denote de­
ceased individuals; SB depicts 
stillborn infants. Presence of 
the mutant alleles is depicted 
by the relevant amino acid sub­
stitution (L219R ) or V2R dele­
tion (de l); normal alleles are 
denoted by a plus sign
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Table  2 Data on dehydration and (DD)AVP tests performed in patients in the three studied families. The age w hen the test was per 
formed is expressed in years (v) or months (w) (/.v. intravenously, i.n. intranasally)
Patients Age Max, urine osmolality 
Before test After test
Rem arks
IV. 1 family 1 2  y 82 105 5.5 h fluid deprivation (serum 
osm. 311) + 0.1 ^.ig/kg D D A V P i.v.
IV .2 family 1 1 m 64 152 4.0 h fluid deprivation (serum 
osm. 303) + 0.3 f-tg/kg D D A V P i,v.
IV. 15 family 2 8 m 1000 1006 51 20 fag D D A V P  i. n.
11 y 76 97 20 jug D D A V P  i. n.
III. 7 family 2 33 y 240 270 Dose o f  D D A V P  i.n. unknown
43 y 225 309 4 0  [xg D D A V P  i.n.
II. 10 family 3 I l  y 1005 1014 Both tests performed with a 
standard test dose  o f  pitressin
16 y 200 No increase A fter  fluid deprivation of unknown 
duration
III. 11 family 3 1 m 1OOO* No increase Standard test dose of pitressin
IV. 3 family 3 8 m 150 No increase Standard test dose o f  D D A V P
1 Specific gravity
Family J
The female patient (patient III. 10) in this Dutch family (Fig.lC) 
presented at the age of 5 months with severe vomiting. Symptoms 
had started after discontinuation of breastfeeding and resulted in a 
3-kg decrease of weight in the following two weeks. Soon thereafter, 
she was admitted to a hospital, where the diagnosis of hypertrophic 
pyloric stenosis was made (no additional medical data available). 
Despite surgical intervention, vomiting and anorexia continued for 
some time but eventually decreased. During childhood, her craving 
for water was remarkable; when she was playing outside for a ioag 
time, she used to eat snow or drink from puddles on the road. For 
this reason, she was hospitalized at the age of 5 years and a diag­
nosis of psychogenic diabetes insipidus was made. Six years later, 
she was again examined for excessive thirst and polyuria, A dehy­
dration test with subsequent administration of  pitressin showed an 
abnormal response ('fable 2). No diagnosis was made, however, 
until she was 16 years old. At that time, her half-brother (patient 
III.I [) was found to suffer from NDl; after a neonatal meningitis, 
he showed persistent hypernatremia and polyuria and no response 
to pitressin ('Pable 1). The diagnosis in this boy made it reasonable 
to evaluate his half-sister for a third time: a dehydration test re­
vealed a maximal urine osmolality of 200  mosmol/kg, despite 
serum hyperosmolality, and pitressin induced no additional rise 
(Table 2). Antidiuretic hormone concentrations during dehydration 
were 6 times the normal value, with concurrent hypotonic urine. Now, 
at adult age, daily urine volume amounts to 8 -1 0  1/day (no m ed­
ication).
When patient 111.10 was 29 years old, her son (patient IV.3) 
was born. At the age o f  K months, he was referred to hospital be­
cause of growth retardation, anorexia, polyuria and a positive fam ­
ily history for NDl. Serum sodium concentration was 174 mmol/1. 
Urine osmolality varied between 100 and 150 mosmol/kg and did 
not rise in response to DDAVP (Table 2); the same diagnosis was 
there fere made as for his mother and uncle.
Family history revealed that two maternal uncles of patient 
III. 10 had died in their first year of life with symptoms of dehy­
dration. Her aunt died from a cause not related to NDL Interpreta­
tion of symptoms of her mother (II.7) was hampered by her history 
of a borderline diabetes mellitus type II and unilateral nephrec­
tomy during adulthood* performed for an unknown reason. H ow ­
ever, she mentioned stress incontinence during childhood, exces­
sive thirst during pregnancy and inability to maintain fluid depri­
vation prior to surgery. The sister o f  patient III. 10 had no sym p­
toms at all.
DDAVP test with measurement o f  extra-renal parameters
Parents of  the patients gave informed consent prior to the tests. 
Tests were performed independently in two different centres, re­
sulting in a few procedural differences.
Procedure  / (family 1)
A dose o f  0 3  j-tg/kg D D A V P (Minrin, Ferring, Malmo, Sweden) 
was administered intravenously over 30 min. Blood pressure and 
pulse rate were recorded every 10 min. A 2,7-ml blood sample was 
collected at time points: - 6 0 ,  0, 30, 60, 90 and 120 min. Blood sam ­
ples were transferred to tubes containing 0.3 ml citrate solution 
and briefly kept in iced w ater  until centrifugation at 2000 rpm. The 
time between blood sampling and perform ance of  the factor VIII 
coagulant (FVIlIe) activity assay did not exceed 4 h. FVIIIc activ­
ity was quantified by a one-stage clotting assay using factor-VIII-  
deficient human plasma according to Lechner (1982). Remaining 
plasma was stored at —70°C. In these samples, tissue type plas­
minogen activator antigen (tPA:Ag) was measured by an enzyme- 
linked immunosorbent assay (Coaliza t-PA, Chromogenix).
Pf ' 0  cedi ire 2 (fami Iy 2)
Protocol 2 is identical to the protocol described by Knoers and Mon- 
nens (1991). Briefly, D D A V P  (0.3 |ag/kg was administered intra­
venously over 10 min. Blood pressure and heart rate were recorded 
at 3-min intervals during the first 25 min and at 10-min intervals 
thereafter. Blood samples were collected and handled as described 
previously (Knoers and Monnens 1991). t-PA:Ag levels were mea­
sured by an enzym e-linked im m unosorben t assay (Innotest, Inno- 
genetics).
DNA analysis
Genomic DNA was isolated from blood cells by the salt-extraction 
technique (Miller et al. 1988). Linkage analysis was performed by
standard procedures using markers defining the loci DXS134, DXS52 
and F8 (family 2) or DXS52, DXS707 and DXS605 (family 3) 
(Knoers et al. 1994), Amplification and direct sequencing of AVPR2 
exons and introns and AQP2 exons were performed as described 
elsewhere (van den Ouweland et al. 1992; Deen et al. 1994).
In family 1, Smal restriction fragment analysis was used to as­
sess inheritance of the mutation. A 526-bp fragment was generated 
by the polymerase chain reaction (PCR) using primers 297 and 300 
(Fig.2, Table 3). After digestion with S m a l  fragments were re­
solved on a 3% agarose gel and visualized by UV irradiation.
In family 2, a PCR fragment with the expected length of 319- 
bp in wild-type DNA was generated with primers 295 and 296, In 
the last cycle» a 32PdCTP was added to the reaction mixture, PCR 
products were digested with Bgll and resulting fragments were sep­
arated by electrophoresis on a 15% non-denaturing polyacrylamide 
gel and subjected to autoradiography,
In family 3, PCR was performed using combinations of primers 
366 and 291, primers 289 and 291, and primers 301 and 291, Car­
rier detection in this family was performed as follows: total DNA 
was digested with BcrmHl, fragments were separated by elec­
trophoresis on a 0 .6 % agarose gel and the standard procedure for 
Southern blotting was applied. A PCR fragment generated with 
primers 301 and 304 and normal genomic DNA as a template, ra- 
dio-actively labelled as described above, was used as the probe.
Results
DDAVP tests
A DDAVP test with measurement of extra-renal parame­
ters was performed in the patients of family 1 and their 
parents, and in patient IV. 15 of family 2. in none of these 
individuals a significant change of blood pressure was found 
during the test (data not shown). Both parents showed a 
slight increase of pulse rate during the DDAVP infusion 
which was absent in the three patients (data not shown), 
Facial flushing was observed only in the father. The in­
crease of t~PA:Ag and FVIIIc activity found in the parents 
did not occur in the patients (Fig, 3, 4). in patient IV. 15 
of family 2, no significant rise of t-PA:Ag was detected 
(FVIIIc not measured) (Fig.3).
DNA analysis 
Family 1
Direct sequencing of all exons and introns of the AVPR2 gene 
demonstrated the presence of a T727 to G transversion in 
exon 2, resulting in substitution of an arginine for a leucine 
(L219R) in the fifth transmembrane region of the predicted 
AVPR2 model, in both affected children. The Smal restric­
tion site introduced by this mutation was present in both af­
fected children and their asymptomatic mother, hut was ab­
sent in their father, maternal grandparents and aunt. The 
526-bp fragment was also present in the affected girl and 
her mother. In the affected girl, sequencing of the complete 
coding region of the AQP2 gene revealed no mutations.
<  Fig. 2  Schematic representation of the AVPR2 gene with the lo­
cation of the primers indicated by arrows. Open boxes  denote (he 
sequences encoding the predicted domains o f  the V2 receptor </:
extracellular; TM transmembrane; C cellular). Hatched boxes  rep­
resent intron sequences
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Table 3 Pi •imers Nr. Position Sequence
366 14-34 5 ' -C A G A G G C T G  A G T C C G C A C A T C -3 '
295 intron 1 ,97-101 5 '-ccg ac tcc tg cccag C T G T G -3 '
297 334-353 5 ' -T G G C T C T G T T C C A A G T G C T G -3 '
296 420-401 5 A C T T C A C G G C C C G A C A C  A G G -3 "
289 560-579 5 ' -T T G G G C C T T C T C G C T C C T T C -3 '
300 859-840 5 ' -G A C A C G T G G G C T C C C T C A C G -3 '
301 761-780 5 ' -G G A G A T T C A T G C C A G T C T G G -3 '
291 1067-1047 5 '-C  A C G C T G C T G C T G  A A A G  A T G C -3 '
304 1252-1233 5 A C G G A A G G A C C C C G A C C  A G G -3 '
Fig. 3 Tissue type plasmino­
gen activator antigen response 
to DDAVP in patients IV. 1 
( - ■ - )  and IV.2 ( - + - )  from 
family 1 and their mother 
( -Y - )  and father ( - A - ) ,  and in 
patient IV. 15 (~x~) from fam­
ily 2. DDAVP was adminis­
tered over 10 min (0 -1 0  min) in 
patient IV. 15 from family 2 
and over 30 minutes (0-30 min) 
in members of family I
F ig .4 Faetor Vlllo activity 
response to DDAVP in patients 
IV, I ( - H —) and IV.2 
from family I and their mother 
(-▼-) and father ( - A - ) .  
DDAVP was administered 
over 30 min (0-30  min)
time (min)
FVIIIc (%)
200
-6 0 30
time (min)
Family 2 adjacent CT nucleotide doublets (337-340) in exon 2, re­
sulting in a frameshift 3 ' to codon 90 in the second trans-
Linkage analysis with polymorphic markers for the Xq28 membrane region with a premature stop codon 101 codons
region showed that the Xq28 ailele shared by the dini- downstream. Segregation of the deletion in the family was
caliy affected women originated from the maternal grand- analysed by detection of a 2-nucleotide size reduction of
father of the proband (data not shown). The AVPR2 gene the wild-type 42-bp fragment generated by Bgll digestion
sequence of the proband revealed a deletion of one of two of the PCR fragment (primers 295 and 296). This proce-
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dure confirmed the presence of the deletion in the proband 
and revealed that this deletion was also present in her 
mother, but absent in her sister and maternal aunts and un­
cles. The 42-bp fragment was also detected in both af­
fected females. Sequencing of the complete AQP2 coding 
region in the affected girl revealed no mutations.
Family 3
Linkage analysis with markers DXS52 and DXS605 
(DXS707 was not informative) showed that all patients 
inherited the same Xq28 allele from their mother. The 
unaffected brother (111.9) of patients III. 10 and III. 11 re­
ceived the other allele. The asymptomatic female and the 
clinically affected female in generation III shared the 
same Xq28 haplotype (data not shown).
In the two affected males, no PCR product could be 
generated using primers 366 and 291 and primers 289 and 
291. The combination of primers 301 and 291, however, 
resulted in the generation of a fragment of approximately 
400bp (including intron 2), indicating a deletion in the 5'- 
region of the gene prior to nucleotide 761. In the affected 
female (III. 10), no absence or abnormalities of any PCR 
products were found and sequencing of the AVP2R gene 
revealed no mutations. In order to assess the earner status 
of the females in this family, the Southern blot procedure 
was employed. In the two male patients, a BamHl frag­
ment with a length approximately lkb larger than that of 
the fragment found in control individuals was detected 
(data not shown). In individuals II.7, III.8 and III. 10, both 
the normal BamHl fragment and the larger fragment were 
detected, indicating that these females are all heterozy­
gous for the deletion in the AVPR2 gene.
Discussion
In most families, NDI shows an X-linked recessive inher­
itance. Variable expression of the disease occurs in some 
of the mothers of these patients, but polyuria and polydip­
sia are generally of such a minimal degree, that these symp­
toms are either not noticed or accepted as a personal char­
acteristic. In addition to these subclinical carriers, severely 
affected females, both isolated and familial cases, have 
been described in the literature (Table 1). Except for the 
autosomal recessive form caused by mutations in the re­
cently discovered AQP2 gene (Deen et al. 1994; van 
Lieburg et al. 1994), the genetic cause of the disease in fe­
male patients has not been elucidated. The present study 
shows that female carriers of an AVPR2 mutation can pre­
sent in early childhood with symptoms resembling the 
clinical phenotype of male NDI patients, with three of the 
four females demonstrating a maximal urine osmolality 
not exceeding 200 mosmol/kg (normally > 805 mosmol/ 
kg).
In family 1, the apparent autosomal recessive inheritance 
of NDI suggests the presence of an AQP2 defect. Because 
of the severity of the disease in the girl and the recent ori­
gin of the AVPR2 mutation, the classical X-linked reces­
sive pattern of heredity is lacking. Although conclusive 
evidence that the L219R substitution causes NDI can only 
be obtained by in vitro expression studies, the change of 
a hydrophilic for a hydrophobic residue in a region in 
which hydrophobicity has been conserved during evolu­
tion (Fahrenholz et al. 1993) indicates that the L219R 
substitution abolishes the normal function of the receptor. 
Moreover, the absence of extra-renal responses in both 
patients is in accordance with a V2 receptor defect (Bichet 
et al. 1988; Knoers and Monnens 1991). The deletions found 
in the other two families undoubtedly impair the function
of the receptor.
Several explanations for the complete manifestation of 
NDI in females deserve consideration. One explanation 
could be homozygosity or compound heterozygosity for an 
AVPR2 mutation or carriership of an AVPR2 mutation in 
combination with an abnormal karyotype (45,X0; 45,XO/ 
46,XX; 46,XY); a second AVPR2 mutation was excluded 
in our patients, and both haplotype analysis and Smal, 
Bgll and BamHl digestion patterns confirmed the pres­
ence of two AVPR2 alleles. The latter findings make the 
possibility of sex chromosome aneuploidy less likely, al­
though mosaicism cannot be excluded. Another possibil­
ity is the presence of other causes of NDI; the involve­
ment of the AQP2 gene was ruled out in two of the female 
patients, and indications of secondary NDI were present
in none of the patients. Clustered occurrence ot female 
symptomatic carriers in certain families could reflect the 
presence of an AVPR2 mutation with more severe func­
tional consequences. Mutations, however, that can be re­
garded as deleterious to the AVP2R protein as the dele­
tions described here have been reported in asymptomatic 
female carriers (Bichet et al. 1993). Moreover, the intra- 
familial variability of expression observed in families I 
and 3 is not in accordance with this explanation.
Skewed X-inactivation, resulting in predominant ex­
pression of the mutant AVPR2 allele, is by far the most 
plausible mechanism underlying the occurrence of differ­
ent phenotypes, varying from no symptoms to full mani­
festation of the disease, in female carriers of an AVPR2 
gene mutation. This phenomenon has been described in 
female carriers of mutations causing other X-linked reces­
sive diseases, including haemophilia A and B, Hunter dis­
ease and Duchenne muscular dystrophy (Ingerslev et al. 
1989; Nisen et aí. 1989; Winchester et aí. 1990; Richards 
et al. 1990; Tihy et al. 1994). in our female patients, the 
absence of extra-renal responses to DDAVP suggests that
predominant inactivation of the X-chromosome carrying 
the wild-type allele occurs in both renal collecting duct 
cells and the extra-renal cells that mediate vasodilation 
and release of coagulation and fibrinolysis factors. A sim­
ilarity ot X-inactivation patterns in different tissues has 
also been described tor Duchenne muscular dystrophy 
(Richards et al. 1990). On the other hand, variation in the 
pattern of X-inactivation between different tissues has 
been reported (Brown et al. 1990) and could result in a 
discrepancy between renal and extra-renal response to 
DDAVP in female carriers of an AVPR2 mutation.
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The observation that female carriers of a mutation in 
the AVPR2 gene can show the clinical phenotype of NDI 
has important implications for genetic counselling and 
DNA research into NDI. We observed this phenomenon in 
a relatively high percentage, viz. 8.8% (3 out of 34) of the 
NDI families in which we found an AVPR2 mutation.
Therefore, if consanguinity of parents is lacking, het­
erozygosity for an AVPR2 mutation is a likely cause of 
NDI in sporadic female patients. Furthermore, the present 
study suggests that, in some of the families in which NDI 
shows a dominant mode of inheritance, an AVPR2 gene 
defect could be the cause of the disease. Consequently, in 
addition to the discovery of the AQP2 gene, this study 
sets the stage for further confinement of the number of 
families with unexplained inheritance of NDI. Finally, for 
clinical practice, it is important to realize that, in female 
carriers of an AVPR2 mutation, clinical and laboratory 
data can be found that resemble those obtained in male 
NDi patients.
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